VodafoneThree bids for TalkTalk consumer business
Acquisition would help UK’s largest mobile operator fulfil ambition to double its broadband business
VodafoneThree has tabled a bid for the consumer operations of struggling rival TalkTalk, as the UK’s largest mobile operator looks to accelerate its expansion into home broadband.
The FTSE 100 group’s UK arm has made a late entry into the long-running auction of TalkTalk’s consumer division, which has 1.75mn customers, after initially declining to participate in the process, according to four people familiar with the matter.
VodafoneThree — formed by the £16.5bn merger between Vodafone UK and Three last year — was one of several companies to submit second-round bids for TalkTalk last week, the people added. New Street Research estimates TalkTalk’s consumer business could be worth between £200mn and £300mn.
The telecoms group, led by chief executive Margherita Della Valle, is seeking to double its UK broadband customer base to more than 4mn by the early 2030s. The company has about 29mn mobile customers.
Vodafone agreed a deal to take full control of the merged company last month, years earlier than expected.
TalkTalk, founded by Sir Charles Dunstone, has struggled since it was bought by London-based hedge fund Toscafund in 2021. The £1.1bn leveraged buyout added £527mn of debt to its balance sheet and left it exposed to rises in interest rates.
TalkTalk’s retail customer base has shrunk from more than 2.5mn in 2023 to 1.75mn as of May.
VodafoneThree said it was “very happy with our organic strategy” on fixed broadband, where it was “the fastest growing in the market”.
“Of course, we always keep a close eye on movements in the market and the sector,” it added.
Alongside efforts to sell its consumer business, TalkTalk is also seeking a buyer for its wholesale division, PXC. The FT reported in March that bidders for PXC included Octopus Investments, a division of Octopus Group, and a private equity-backed management buyout led by executive chair Tom O’Hagan.
TalkTalk’s largest shareholder, Ares, has made several cash injections into the company in recent years to help it cover costs and pay its bills, as it struggled with cash flow problems.
The FT reported last year that Openreach had threatened to block TalkTalk from putting new customers on its broadband network in a dispute over late payments.
TalkTalk declined to comment.
Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SAIL -13.5%, DBI -10.8%, UNFI -9.2%, UEC -4.8%, LE -4.4%, MTN -4.2%, AVO -2.8%
Other news:
- IDYA -7.7% (prices $300 mln equity offering consisting of common stock and warrants)
- NOVT -5.1% (to acquire Riverpoint Medical for up to $1.45 bln; reaffirms outlook; announces $300 million private placement)
- ATHE -5.1% (achieves alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in multiple system atrophy)
- PRGO -2.4% (CEO resigns; names interim CEO)
- SPRB -2% (long-term Tralesinidase Alfa Enzyme Replacement Therapy data in Sanfilippo Syndrome Type B)
- OCS -1.2% (announces first patient randomized in PREDICT-1 registrational trial of licaminlimab, advancing precision medicine in dry eye disease)
- HNI -1.1% (unit introduces Levra, a new standard in performance seating)
- WCC -0.9% (to acquire Newark Engineering Group)
Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CECO +6.8% (updates 2026 outlook following Thermon acquisition) SJM +6%, ASX +2.8% (reports May revs), ODC +1.9%,
Other news:
- NUVL +38.9% (Nuvalent to be acquired by GSK for $124 per share in cash)
- APLD +10.9% (signs 210 MW lease at Delta Forge 2)
- FCEL +9.8% (files mixed securities shelf offering)
- SPTX +4.3% (reports multiple-ascending dose data from Phase 1 Proof-of-Concept Trial of GlyphAgo in healthy volunteers)
- SRE +4% (SRE unit, Qualcomm and UC San Diego launch edge AI collaboration)
- TNGX +3.7% (stock offering)
- SIRI +3.5% (to join S&P MidCap 400)
- QCOM +2.7% (SRE unit, Qualcomm and UC San Diego launch edge AI collaboration)
- SVRA +2.6% (CFO to step down; COO to assume additional role of CFO)
- SATL +2.3% (Satellogic and Rick Dunn mutually agreed that Mr. Dunn will step down as the Company's Chief Financial Officer at the conclusion of a transition period agreed between Mr. Dunn and the Company)
- NIO +1.7% (states U.S. CMC designation will not affect operations)
- PONY +1.6% (launches Luxembourg autonomous mobility pilot with Bolt and Stellantis)
- DBVT +1.4% (to present new positive data from VITESSE Study and preview recently initiated THRIVE Study)
- BKD +1.3% (reports May occupancy)
- TFX +1.3% (Four-Year BIOMAG-I study results presented at EuroPCR confirm long-term safety and sustained performance of the Freesolve resorbable magnesium scaffold)
- BIDU +1.2% (states U.S. CMC designation will not affect operations)
- ZLAB +1% (receives China approval for TIVDAK in cervical cancer)
Research Calls I
-
Upgrades:
- Arthur J. Gallagher (AJG) upgraded to Buy from Neutral at UBS, tgt $250
- Brady (BRC) upgraded to Buy from Neutral at Sidoti, tgt $103
- FuelCell Energy (FCEL) upgraded to Buy from Hold at Canaccord, tgt $30
- Jumia Technologies (JMIA) upgraded to Buy from Sell at Aletheia, tgt $7.50
- PAR Technology (PAR) upgraded to Neutral from Underweight at JPMorgan, tgt $16
- Toll Brothers (TOL) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $161
- West Pharmaceutical (WST) upgraded to Overweight from Equal Weight at Barclays, tgt $400
- Arthur J. Gallagher (AJG) upgraded to Buy from Neutral at UBS, tgt $250
-
Downgrades:
- Equity Residential (EQR) downgraded to Sector Perform from Outperform at RBC Capital, tgt $70
- Ingredion (INGR) downgraded to Perform from Outperform at Oppenheimer
- Lennar (LEN) downgraded to Underperform from Market Perform at Keefe Bruyette, tgt $86
- Equity Residential (EQR) downgraded to Sector Perform from Outperform at RBC Capital, tgt $70
-
Others:
- Cerebras Systems (CBRS) initiated with a Buy at Craig-Hallum, tgt $325
- Enliven Therapeutics (ELVN) initiated with a Buy at Stifel, tgt $60
- FrontView REIT (FVR) initiated with a Strong Buy at Raymond James, tgt $22
- Gold.com (GOLD) initiated with a Buy at Canaccord, tgt $70
- International Flavors & Fragrances (IFF) initiated with a Buy at Benchmark, tgt $100
- Grand Canyon Education (LOPE) initiated with a Buy at Truist, tgt $100
- LSI Industries (LYTS) initiated with an Outperform at Oppenheimer, tgt $30
- Magnite (MGNI) initiated with a Buy at BTIG, tgt $20
- Park Aerospace (PKE) initiated with an Outperform at Citizens, tgt $42
- PTC Therapeutics (PTCT) assumed with a Buy from Neutral at Citi, tgt $108
- Ralliant (RAL) assumed with an Outperform at Evercore ISI, tgt $80
- Spruce Biosciences (SPRB) initiated with a Buy at JonesResearch, tgt $135
- WPP (WPP) initiated with a Buy at Berenberg
- Cerebras Systems (CBRS) initiated with a Buy at Craig-Hallum, tgt $325
Early premarket gappers
-
Gapping up:
- NUVL +38.8%, ATHE +13.5%, APLD +11.5%, FCEL +7.7%, SRE +4%, SIRI +3.7%, QCOM +2.9%, ASX +2.5%, SVRA +2%, PONY +1.8%, YSS +1.7%, TNGX +1.6%, NIO +1.6%, BKD +1.5%, SATL +1.4%, TFX +1.3%, ZLAB +1.2%, BIDU +1.1%, ODC +1%, Q +0.9%, LKFT +0.8%, GHI +0.8%
-
Gapping down:
- IDYA -9.1%, MTN -4.2%, AVO -4.2%, NOVT -3.9%, PRGO -3.8%, OCS -1.9%, UEC -1.6%, GSK -1.2%, HNI -1.1%, WCC -0.9%, EGY -0.9%, GILD -0.7%, NBIX -0.7%
Why Apple’s slow-and-steady AI bet is starting to look pretty smart
For years, Apple has been accused of being one of the biggest stragglers in the AI arms race. Doubters have argued that Apple’s lack of a clear AI strategy have cost it its edge, and Wall Street analysts have worried that the gap could start hurting iPhone sales.
Now, the company has unveiled what it is billing as its biggest AI launch to date: Siri AI, which embeds new automated capabilities (fueled by a partnership with Google Gemini) into the very spine of its software.
Is it enough to get people to stop saying that Apple is “losing” the AI race?
To be honest, nobody really knows. But the question itself may be the wrong one. A better one might be: are Apple customers actually going to use these features and, if they do, will it help Apple’s business?
Before we address that question, we should note that Monday’s announcements also came with an interesting comment from Craig Federighi, Apple’s senior vice president of software engineering.
“Some appear to be racing forward, seemingly pursuing AI for the sake of AI, without clear regard for the people — all of us — that it’s ultimately meant to serve,” Federighi said during his remarks. “At Apple, our mission has always been to turn the potential of advanced technology into helpful and intuitive products for everyone.”
The not-so-veiled defiance on display here seems like both a response to Apple’s “behind-on-AI” criticism and an effort to acknowledge the deeply ambivalent — and, according to some polls, increasingly negative — sentiments that many consumers have about the AI industry. It’s also a shrewd message at a moment when Americans are worried that AI will take their jobs and rot their brains. Apple is positioning itself as the AI company that’s actually on your side.
Judging by Monday’s demos, that positioning has some substance behind it. Siri can now surface information buried deep in your inbox or text history and surface helpful information and offer helpful suggestions based on it. It can use what Apple calls onscreen awareness to give you context about what you’re looking at. And — using Gemini — it can pull near-instantaneous up-to-date information from the web and deliver it right to your device.
Siri is also designed to work seamlessly across Apple devices, giving users increased flexibility and, like other AI chatbots, it stores chat histories so users can revisit past conversations.
By building AI functionalities into its disembodied, ethereal assistant, Apple also has the potential to eat into the advantages of competitors whose apps can only reach users through its own App Store. For those competitors, having Apple’s AI embedded at the operating system level is a meaningful threat to their distribution advantage.
The keyword here is “potential” since this version of Siri won’t be available to consumers until later this year, as a beta.
A final verdict will have to wait, but what’s already clear is that Apple is doing its best to court its audience — whether they end up going for it or not. Apple is obviously a hardware company, and these updates are designed to make that hardware incrementally more user-friendly and convenient, keeping users glued to their devices a little while longer.
The contrast with its competitors is instructive and maybe the most important signal in Monday’s announcements for anyone watching where the AI industry is actually headed. Take OpenAI, which, despite shipping updates at a relentless pace, has struggled to define who it’s actually selling to, oscillating between consumers and enterprises. Or Meta, which is pouring gargantuan sums into AI without a clear explanation of how it connects to the company’s core advertising business.
Apple’s more measured approach is starting to look optimal by comparison — and more financially sound. For the most part, Apple hasn’t needed a gangbusters AI strategy. It posted historic iPhone sales last quarter. And as questions mount over AI’s profitability and real-world utility, Apple is spending significantly less than its competitors — roughly $14 billion in capex planned this year, against a cumulative $900 billion being committed by other tech giants — while still earning huge amounts of revenue. That revenue has come from the AI industry itself via taxes on AI companies that use its App Store to platform their apps.
In short, Apple is spending less, making more, and now launched a suite of AI features that — for many iPhone users — will feel indistinguishable from the other AI applications already available to them through the App Store. If that doesn’t exactly count as “winning the AI race,” it may be the smartest way to run it.